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Indoor dampness and mold problems are uni-
versal and thus are potentially of major public
health importance (1–11). Such problems
have been surprisingly common in countries
with cold climates, such as Finland, Sweden,
and Norway (4,5,9,11). The major reasons
for the high frequency of such problems in
cold climates may be insufﬁcient maintenance
of the buildings and construction of tight
buildings to conserve energy accompanied by
inadequate ventilation. Residential dampness
problems have been related to increased risk
of asthma and asthma-related symptoms in
children (1,2,4,6,8,12–15) and in adults
(7,9,13,15–20). However, we did not identify
any epidemiologic study of workplace indoor
dampness and mold problems and asthma,
and only four studies have evaluated potential
effects of such problems on wheezing
(5,10,21,22). These studies were carried out
in either daycare centers or ofﬁces. Most of
the studies among adults were cross-sectional
or prevalent case–control studies in design,
and almost all of them based the diagnosis of
asthma or asthma-related symptoms on self-
report in questionnaires or interviews.
The objective of our study was to assess
the role of dampness problems and molds at
work and at home in the development of
asthma in working-age population. We
recruited incident cases of asthma, the diag-
nosis being verified with clinical examina-
tions. We also evaluated some personal
characteristics, such as age, sex, and smoking,
as potential indicators of sensitivity to the
adverse effects of dampness problems.
Methods
Study Design
This study was a population-based incident
case–control study. The source population
consisted of adults 21–63 years old living in
the Pirkanmaa Hospital district. This district
is a geographically defined administrative
area in South Finland with a population of
440,913 inhabitants in 1997. Our goal was
to recruit all the new cases of asthma in the
source population during the study. We
selected controls randomly from the source
population based on 1997 census data. The
ethics committees of the Finnish Institute of
Occupational Health and the Tampere
University Hospital approved the study.
Deﬁnition and Selection of Cases
We systematically recruited all the new cases
of asthma, first in the city of Tampere
beginning on 15 September 1997, and then
in the whole Pirkanmaa Hospital district
from 10 March 1998 to 31 March 2000.
We recruited patients at all health care facil-
ities diagnosing asthma, including the
Department of Pulmonary Medicine at the
Tampere University Hospital, ofﬁces of the
private-practicing pulmonary physicians in
the region, and public health care centers.
As an additional route of case selection, the
National Social Insurance Institution of
Finland invited all patients to participate
whose reimbursement rights for asthma
medication began during the period 1
September 1997 through 1 May 1999 and
who had not yet participated.
We applied the following diagnostic cri-
teria for asthma: a) history of at least one
asthmalike symptom (prolonged cough,
wheezing, attacks of or exercise-induced dys-
pnea, or nocturnal cough or wheezing) and
b) demonstration of reversibility in airway
obstruction in lung function investigations.
Table 1 presents lung function findings
accepted to demonstrate reversibility. These
diagnostic procedures correspond to the rec-
ommendations of the National Asthma
Program in Finland (23).
We selected as cases all the confirmed
cases of asthma fulﬁlling the general eligibil-
ity criteria. A total of 362 cases (response
rate, 90%) participated through the health
care system, and 159 cases participated
through the National Social Insurance
Institution (response rate, 78%), totaling 521
cases overall.
Selection of Controls
We randomly selected the controls from the
source population using the national popula-
tion registry, which has full coverage of the
population. We applied the general eligibil-
ity criteria for controls. After up to three
invitation letters and phone calls, 1,016 par-
ticipated in the study (response rate, 67% of
total invited population, or 80% of those
who had a phone number in the Pirkanmaa
area). Previous or current asthma was
reported by 76 (7.5%); six persons were
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Articles
Previous cross-sectional and prevalent case–control studies have suggested increased risk of
asthma in adults related to dampness problems and molds in homes. We conducted a population-
based incident case–control study to assess the effects of indoor dampness problems and molds at
work and at home on development of asthma in adults. We recruited systematically all new cases
of asthma during a 2.5-year study period (1997–2000) and randomly selected controls from a
source population consisting of adults 21–63 years old living in the Pirkanmaa Hospital district,
South Finland. The clinically diagnosed case series consisted of 521 adults with newly diagnosed
asthma and the control series of 932 controls, after we excluded 76 (7.5%) controls with a history
of asthma. In logistic regression analysis adjusting for confounders, the risk of asthma was related
to the presence of visible mold and/or mold odor in the workplace (odds ratio, 1.54; 95% conﬁ-
dence interval, 1.01–2.32) but not to water damage or damp stains alone. We estimated the frac-
tion of asthma attributable to workplace mold exposure to be 35.1% (95% conﬁdence interval,
1.0–56.9%) among the exposed. Present results provide new evidence of the relation between
workplace exposure to indoor molds and adult-onset asthma. Key words: asthma, case–control study,
molds, occupational exposure, population-based. Environ Health Perspect 110:543–547 (2002).
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incomplete questionnaires. After excluding
these persons, our study population included
932 controls.
Exposure Assessment
We based exposure assessment on question-
naire information about water damage,
damp stains and other marks of structural
dampness, visible mold, and mold odor,
both at home and indoors at work (4,5). For
water damage, damp stains, and visible
mold, we asked for information about their
occurrence during the past year, 1–3 years
before, or > 3 years before. For mold odor,
we asked the subject about occurrence dur-
ing the past year and to indicate if such odor
appeared almost daily, 1–3 days a week, 1–3
days a month, < 1 day a month, or never.
Data Collection
At the Tampere University Hospital, we
recruited cases at their ﬁrst visit for suspected
asthma, and we veriﬁed the diagnosis in clin-
ical examinations. At the other health care
facilities, cases were recruited immediately
when their asthma diagnosis was verified.
We applied the same protocol for diagnosing
asthma at all health care facilities. The
National Social Insurance Institution invited
the cases 6 months to 2 years after their diag-
nosis was established. For these patients, we
conﬁrmed the date and criteria of the asthma
diagnosis from their medical records to
ensure that the diagnosis of asthmatics
included in our study fulfilled our criteria.
For all cases, we veriﬁed from their medical
records that they did not have a previous
asthma diagnosis. Eligible subjects were
invited to participate in the study, and
informed consent was asked by their physi-
cian or through a letter sent by the National
Social Insurance Institution. The cases
answered the questionnaire at the time of
recruitment. Recruitment of controls took
place at regular intervals throughout the study
period. Informed consent was requested in
the letter and returned in a prepaid envelope
to the research nurse of the study project.
Measurement Methods
Questionnaire. The self-administered ques-
tionnaire, modiﬁed from the Helsinki Ofﬁce
Environment Study questionnaire (24,25) to
be used in a general population, included six
sections: 1) personal characteristics, 2) health
information, 3) active smoking and environ-
mental tobacco smoke exposure, 4) occupa-
tion and work environment, 5) home
environment, and 6) dietary questions.
Lung function measurements. We
applied the same lung function protocol to
all patients with suspected asthma. The only
exception was patients recruited through the
National Social Insurance Institute, for
whom we obtained lung function data by
abstracting from the medical records.
Baseline spirometry. For all patients with
suspected bronchial asthma, we recorded vital
capacity and ﬂow-volume curves with a pneu-
motachygraph spirometer connected to a
computer and using a disposable ﬂow trans-
ducer (Medikro 905; Medikro Ltd., Kuopio,
Finland). We carried out the measurements
according to the standards of the American
Thoracic Society (26). We judged presence of
obstruction using the reference values derived
from a Finnish population (27).
Bronchodilation test. After baseline
spirometry, all patients received 400 µg of
salbutamol (albuterol) with a spacer and
performed spirometric flow-volume curves
after 10 min.
Peak expiratory flow (PEF) follow-up.
All patients performed PEF follow-up for at
least 2 weeks with a mini Wright meter. We
instructed subjects to carry out measure-
ments twice a day, in the morning and in
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Table 1. Lung function findings confirming reversibility of obstruction among asthma cases, Finnish
Environment and Asthma Study 1997–2000.
Lung function criteria
1. Signiﬁcant improvement in response to short-acting bronchodilating medication in a bronchodilator test. Criteria
for signiﬁcant changes:
FEV1 ≥ 15%
FVC ≥ 15%
PEF ≥ 23%
and/or
2. Daily variationa ≥ 20% and/or ≥ 15% improvementa in response to short-acting bronchodilating medication during
at least 2 days in a 2-week diurnal PEF follow-up.
and/or
3. Signiﬁcant improvement in spirometric lung function (criteria given in item 1) and/or ≥ 20% improvement in the
average PEF level in response to a 2-week oral steroid treatment.
Abbreviations: FEV1, forced expiratory volume in 1 sec; FVC, forced vital capacity; PEF, peak expiratory ﬂow.
aCalculated according to the standard practice of the Tampere University Hospital: maximum daily variation = (highest
PEF value during the day –  lowest PEF value during the day)/highest PEF value during the day; bronchodilator response =
(highest PEF value after bronchodilating medication – highest PEF value before medication)/highest PEF value before
medication.
Table 2. Characteristics of the study population, Finnish Environment and Asthma Study 1997–2000.
Cases Controls
Characteristic No. Percent No. Percent
Total 521 932
Sex
Male 175 33.6 438 47.0
Female 346 66.4 494 53.0
Age (years)
21–29 108 20.7 141 15.1
30–39 107 20.5 224 24.0
40–49 125 24.0 254 27.3
50–59 140 26.9 240 25.8
60–63 41 7.9 73 7.8
Parental allergic diseases
Maternal allergy 85 16.3 108 11.6
Paternal allergy 47 9.0 48 5.2
Maternal asthma 66 12.7 64 6.9
Paternal asthma 62 11.9 48 5.2
Any 186 35.7 204 21.9
Educationa
No vocational schooling 107 20.6 154 16.6
Vocational course 89 17.2 104 11.2
Vocational institution 149 28.7 271 29.2
College-level education 113 21.8 261 28.1
University or corresponding 61 11.8 138 14.9
Smokingb
Never 239 46.1 487 52.4
Formerly 133 25.7 203 21.8
Currently 146 28.2 240 25.8
Environmental tobacco smoke
In the workplace 89 17.1 130 13.9
In the home 30 5.9 52 5.6
Pets at home
Sometimes 387 74.3 663 71.1
Any work exposurec 313 60.1 579 62.1
aInformation on education was missing for six subjects. bInformation on smoking was missing for five subjects. cSelf-
reported exposure to sensitizers, dusts, and/or fumes, except for exposure to molds.the evening. During the second week, sub-
jects performed measurements before and 15
min after short-acting bronchodilating med-
ication. Subjects recorded all three readings,
and we used the highest value in the analyses.
Steroid treatment response. We recom-
mended that physicians give a 2-week oral
steroid treatment to those with a strong sus-
picion of asthma, if the other diagnostic tests
were negative. The patient was asked to per-
form 2 weeks of PEF follow-up during this
treatment, and spirometry was carried out
again at the end of this treatment period to
judge the response.
Statistical Methods
We used exposure odds ratio (OR) to quan-
tify the relations between exposures and
outcome, and estimated adjusted OR in logis-
tic regression analysis. We used the following
covariates to adjust for potential confounding:
sex, age, parental atopy or asthma, education
(as an indicator of socioeconomic status), per-
sonal smoking, dampness and mold problems
in the home or at work, exposure to environ-
mental tobacco smoke, any history of pets in
the home, and self-reported occupational
exposure to sensitizers, dusts or fumes (except
self-reported exposure to molds).
We studied the independent predictive
value of the four exposure indicators (water
damage, damp stains, visible mold, and
mold odor) in the workplace (for those
working at least 50% of their workday
indoors) and in the home by including all
the exposure indicators as well as covariates
in the model. We also elaborated the role of
exposure time period by ﬁtting time-speciﬁc
exposure variables. We combined occurrence
of dampness and mold problems during dif-
ferent time periods because we detected no
meaningful trends according to the time
speciﬁcity of exposure (data not shown). We
combined any visible mold and/or mold
odor in the workplace to represent the main
exposure parameter. These two exposure
indicators were closely related and had
strong overlap, so including them separately
in the models was not meaningful. The ref-
erence category consisted of those reporting
no mold or dampness exposure. We also
analyzed the data after excluding patients
recruited by the National Social Insurance
Institution. 
We systematically studied potential
modification of the relation between main
exposure parameter and risk of asthma by
comparing the adjusted ORs by sex, age
(20–29, 30–49, and 50–63 years), parental
atopy or asthma (yes/no), and smoking
(never, former, current).
Finally, we quantified the impact of
exposure as an attributable fraction (28) or
etiologic fraction (29), providing the fraction
of exposed cases for whom the disease is
attributable to the exposure (28). We calcu-
lated the attributable fraction (AF) 
AF = (OR – 1)/OR,
where OR is the adjusted OR due to the
exposure of interest, an unbiased estimate of
incidence ratio in a population-based
case–control study (29). We calculated the
95% conﬁdence interval (CI) using the cor-
responding interval of OR.
Results
Characteristics and Exposure of
Cases and Controls
A larger proportion of cases than controls
were women, young, current smokers, and
exposed to environmental tobacco smoke
and to pets; had lower education; and
reported a history of parental allergic diseases
(Table 2). 
A larger percentage of cases than controls
reported presence of visible mold (6.6% vs.
4.5%) and mold odor (11.3% vs. 9.3%) in
the workplace (Table 3). The frequency dis-
tributions of water damage and damp stains
or paint peeling in the workplace and of all
the four exposure indicators in the home
were similar among cases and controls.
Indoor Dampness Problems and
Molds and the Risk of Asthma
The risk of asthma was related to the pres-
ence of visible mold and/or mold odor in the
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Table 3. Distribution of exposure indicators in cases and controls, Finnish Environment and Asthma Study
1997–2000.
Cases Controls
Exposure indicator No. Percent No. Percent
Work
Water damagea
No 458 87.9 811 87.0
Yes, during past 12 months 32 6.2 53 5.7
Yes, 1–3 years ago 20 3.8 42 4.5
Yes, > 3 years ago 11 2.1 26 2.8
Damp stains or paint peelinga
No 431 82.6 761 81.7
Yes, during past 12 months 66 12.7 108 11.6
Yes, 1–3 years ago 18 3.5 32 3.4
Yes, > 3 years ago 6 1.2 31 3.3
Visible molda
No 487 93.4 890 95.5
Yes, during past 12 months 24 4.6 30 3.2
Yes, 1–3 years ago 6 1.2 10 1.1
Yes, > 3 years ago 4 0.8 2 0.2
Mold odor during past 12 monthsa
No 462 88.7 846 90.7
Yes, almost daily 25 4.8 39 4.2
Yes, 1–3 days per week 11 2.1 13 1.4
Yes, 1–3 days per month 7 1.3 9 1.0
Yes, < 1 day per month 16 3.1 25 2.7
Home
Water damageb
No 462 88.7 817 87.7
Yes, during past 12 months 11 2.1 15 1.6
Yes, 1–3 years ago 10 1.9 27 2.9
Yes, > 3 years ago 33 6.3 61 6.5
Damp stains or paint peelingb
No 418 80.2 744 79.8
Yes, during past 12 months 54 10.4 85 9.1
Yes, 1–3 years ago 22 4.2 51 5.5
Yes, > 3 years ago 27 5.2 49 5.3
Visible moldb
No 494 94.7 875 93.9
Yes, during past 12 months 18 3.5 28 3.0
Yes, 1–3 years ago 5 1.0 18 1.9
Yes, > 3 years ago 3 0.6 10 1.1
Mold odor during past 12 months
No 467 89.6 846 90.7
Yes, almost daily 17 3.3 23 2.5
Yes, 1–3 days per week 7 1.3 8 0.9
Yes, 1–3 days per month 10 1.9 20 2.1
Yes, < 1 day per month 20 3.9 35 3.8
aYes categories included only those who worked indoors at least 50% of their work day; others are included in the no
category. b”Do not know” was answered by 5 cases and 12 controls for water damage, three controls for damp stains,
and one case and one control for visible mold.workplace, but not to water damage or
damp stains alone, as shown in Table 4. The
adjusted OR for any exposure to visible
mold or mold odor was 1.54 (95% CI,
1.01–2.32). The risk of asthma was related
to none of the exposure indicators in the
home. The results were essentially similar in
the analyses that excluded cases recruited
through the National Social Insurance
Institution. We estimated the fraction of
asthma attributable to workplace mold expo-
sure to be 35.1% (95% CI, 1.0–56.9%)
among the exposed.
The relation between workplace mold
exposure and the risk of asthma was slightly
stronger in women than in men (Table 5).
The relation was strongest in the youngest
age group and stronger in current smokers
than in former smokers or never smokers.
The relative risk was essentially similar in
those with and without parental atopy.
Discussion
We found a significantly increased risk of
new asthma in adults in relation to the pres-
ence of visible mold and/or mold odor in the
workplace, whereas water damage or damp
stains alone were not associated with asthma.
The mechanisms by which indoor dampness
problems could lead to an increased risk of
asthma are not well understood, and several
potential causes have been suggested: molds,
bacteria, house dust mites, and enhanced
emission of chemicals from surface materials
(9,15). Our results emphasize the role of
molds (and possibly bacteria) as an impor-
tant cause of asthma, rather than dampness
per se. Potential mechanisms by which
indoor molds could induce asthma include
immunoglobulin E–mediated hypersensitiv-
ity reactions, toxic reactions caused by myco-
toxins, and nonspecific inflammatory
reactions caused by irritative volatile organic
compounds produced by microbes or cell
wall components, such as 1,3-β-D-glucan
and ergosterol (9,30–32). Different species
of molds may induce asthma by different
mechanisms, or molds may induce health
effects by combined mechanisms (32).
The risk of asthma was not associated
with the presence of dampness or molds at
home in this study. We have no reason to
believe that effects of similar exposures at
home and at work would be different.
Rather, the difference in effect estimates in
our study are likely explained by more exten-
sive mold problems at work than at home.
We did not quantify the extent of such
problems, but it is likely that in the work-
place people do not notice small dampness
problems easily, because they change work
areas often, and thus more extensive mold
growth may develop. In addition, inﬂuenc-
ing the work environment is often more dif-
ﬁcult. At home, people tend to pay attention
to water damage and repair it before more
advanced mold problems develop, because
such damage reduces the value of the prop-
erty. In 1998 in the Pirkanmaa area, 67% of
the population owned the residences in
which they lived. Other potential explana-
tions for these differences include, for exam-
ple, ventilation systems of workplaces
favoring the spread of molds and their
metabolites into indoor air. The attributable
fraction of asthma due to workplace mold
was surprisingly high: 35% among the
exposed cases.
We found that women, the young, and
smokers are especially susceptible to the
effects of workplace molds. The mechanisms
of such susceptibility are not known and
should be studied further. The young and
women may have more extensive exposures,
because they are often in lower positions in
the workplace and therefore have less inﬂu-
ence on their work environment. Also,
modification of immunologic or other
inflammatory reactions may play a role in
sensitivity, at least in current smokers.
Validity Issues
We were able to recruit a high proportion of
new cases of asthma by a thorough recruit-
ment through the health care system
(response rate, 90%) and with the help of
the National Social Insurance Institution
providing us a route to reach those asthmat-
ics that we missed by our recruitment sys-
tem (response rate, 78%). The health
insurance provided by the National Social
Insurance Institution covers the whole
Finnish population, and its medication ﬁles
have practically a full coverage of asthmatics
who fulﬁll the diagnostic criteria required for
reimbursement in Finland. The response
rate among the control population was also
relatively high, especially among those who
had a phone number in the Pirkanmaa
region and were likely to really live in this
area during our study period. Thus, any
major selection bias is unlikely in our study.
To reduce information bias, we intro-
duced the study to the participants as a study
on environmental factors and asthma in gen-
eral (the Finnish Environment and Asthma
Study), with no special focus on mold and
dampness problems. We collected informa-
tion on exposures in a similar way from cases
and controls. The physicians responsible for
the diagnostic procedures of asthma were
unaware of the questionnaire responses of
the study subjects. Our finding of an
increased risk of asthma in relation to work-
place exposure but not in relation to home
exposure supports unbiased reporting; it is
unlikely that subjects would associate their
symptoms to a speciﬁc exposure in one envi-
ronment but not in the other. In the analy-
ses excluding cases recruited by the National
Social Insurance Institution (i.e., some time
after their diagnosis was made), the OR
related to workplace mold exposure
remained increased (1.38) but was slightly
reduced. This indicates that some overre-
porting of workplace exposure may have
taken place, but this does not explain the
effect entirely. On the other hand, studies
comparing self-reported dampness with site
visits have usually shown that subjects tend
to underestimate their exposures (7,9,11).
Thus, self-report of exposures may have led
to some underestimation of the risks in our
study (e.g., the risks for home exposures).
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Table 4. Adjusted ORs of asthma in relation to exposure to mold and dampness in the workplace and at
home, Finnish Environment and Asthma Study 1997–2000.
Exposure/history ORa 95% CI
Work
Visible mold or mold odor 1.54 1.01–2.32
Damp stains or paint peeling  0.84 0.56–1.25
Water damage 0.91 0.60–1.39
Home
Visible mold or mold odor 0.98 0.68–1.40
Damp stains or paint peeling 1.02 0.73–1.41
Water damage 0.90 0.61–1.34
aAdjusted for sex, age, parental atopy/asthma, education, smoking, environmental tobacco smoke exposure, pets, work
indoors, self-reported occupational exposures, and other exposure indicators shown in the table.
Table 5. Adjusted ORs of asthma in relation to vis-
ible mold and/or mold odor in the workplace
according to potential effect modifiers, Finnish
Environment and Asthma Study 1997–2000.
Study population ORa 95% CI
All 1.54 1.01–2.32
Sex
Male 1.26 0.62–2.54 
Female 1.67 1.00–2.79 
Age (years)
20–29 2.98 0.96–9.27 
30–49 1.31 0.75–2.30
50–63 1.46 0.65–3.29
Parental atopy
Yes 1.57 0.57–4.31 
No 1.61 1.02–2.55
Smoking
Currently 3.05 1.14–8.14
Formerly 0.83 0.32–2.10
Never 1.63 0.92–2.90
aAdjusted for sex, age, parental atopy/asthma, educa-
tion, smoking, environmental tobacco smoke exposure,
pets, work indoors, self-reported occupational expo-
sures, and other exposure indicators.We deﬁned asthma on the basis of objective
clinical findings to eliminate information
bias concerning the outcome.
We were able to adjust for a number of
potential confounders (see “Statistical
Methods”) in logistic regression analysis to
eliminate these factors as potential explana-
tions for our results. We adjusted for parental
atopy to control for genetic predisposition,
but not for subjects’ own atopy, because this
may be in the causal pathway for effects of
indoor molds.
Synthesis with Previous Knowledge
Earlier studies on indoor dampness and
mold problems in adults have been mainly
cross-sectional or prevalent case–control
studies in design; therefore, our results can-
not be compared directly with them. One
population-based study from Sweden
assessed adult-onset asthma based on ques-
tionnaire reports of asthma (20). A signifi-
cant OR of 2.2 was reported in relation to
visible mold at home, whereas visible damp-
ness alone was not significantly related to
asthma. The Swedish study assessed the
onset of asthma retrospectively based on self-
reported information about the year of diag-
nosis. The subjects had to recall both the
year of diagnosis and exposures as far back as
14 years before, which makes the study vul-
nerable to recall bias. The Swedish study did
not adjust for or estimate the risk related to
workplace mold problems. 
We identified no earlier study that had
assessed the relation between workplace
dampness and mold problems and the risk of
asthma. A previous study in Finnish daycare
nurses reported the risk of wheezing related
to workplace exposure, while adjusting for
home exposure (5). The OR was 1.66 when
water damage was present and 1.28 when
water damage and mold odor both were pre-
sent. These estimates are close to our OR of
asthma among women (1.67). In addition,
three other studies reported risk estimates of
wheezing in relation to workplace dampness
or mold exposures. A study from the United
States reported an OR of 2.8 for usual
wheezing and 1.9 for occasional wheezing in
association with mold exposure in problem
office buildings in Florida (22). A study of
Taiwanese daycare centers found an
increased risk of wheezing in relation to
stuffy odor (OR, 1.38), visible mold (OR,
1.39), and water damage (OR, 1.32) (21).
Another Taiwanese study of office workers
found similar ORs for chest tightness and
chest pain (10).
Two Dutch studies assessed the risk of
asthma related to residential dampness strati-
ﬁed by sex. In one of them (18) the risk was
similar in men (OR, 1.29) and women (OR,
1.25), whereas the other (13) found, in
agreement with our study, a greater risk in
women (OR, 4.16) than in men (OR, 1.15).
The Swedish study (20) found an essentially
similar risk of asthma related to visible mold
growth among men (2.7) and women (2.0).
Modiﬁcation by age, genetic predisposition,
or smoking status has not been previously
studied.
Conclusion
The present results provide new evidence of
the relation between workplace exposure to
indoor molds and development of asthma in
adulthood. Our ﬁndings suggest that indoor
mold problems constitute an important
occupational health hazard.
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